|
KIAA1715 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.916800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.148000E-02 |
| Normal-vs-Stage2 |
9.522200E-01 |
| Normal-vs-Stage3 |
1.280610E-01 |
| Normal-vs-Stage4 |
2.876600E-01 |
| Stage1-vs-Stage2 |
2.677800E-01 |
| Stage1-vs-Stage3 |
2.111600E-02 |
| Stage1-vs-Stage4 |
1.199420E-01 |
| Stage2-vs-Stage3 |
1.806990E-01 |
| Stage2-vs-Stage4 |
2.324800E-01 |
| Stage3-vs-Stage4 |
9.474400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.913800E-01 |
| Normal-vs-AfricanAmerican |
6.407400E-01 |
| Normal-vs-Asian |
7.434600E-01 |
| Caucasian-vs-AfricanAmerican |
8.919600E-01 |
| Caucasian-vs-Asian |
6.241600E-01 |
| AfricanAmerican-vs-Asian |
6.427400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.724100E-03 |
| Normal-vs-Female |
2.000500E-03 |
| Male-vs-Female |
2.43160000001907E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.797600E-01 |
| Normal-vs-Extreme_Weight |
2.229300E-04 |
| Normal-vs-Obese |
3.191600E-01 |
| Normal-vs-Extreme_Obese |
2.634400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.801900E-02 |
| Normal_Weight-vs-Obese |
3.480200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.589200E-01 |
| Extreme_Weight-vs-Obese |
1.641860E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.212000E-01 |
| Obese-vs-Extreme_Obese |
2.544200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.488030E-01 |
| Normal-vs-Age(41-60Yrs) |
4.815000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.484190E-02 |
| Normal-vs-Age(81-100Yrs) |
7.959500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.078400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.006500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.046300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.117500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.388960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.097000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.083300E-03 |
| Normal-VS-Type2 PRCC |
4.151200E-01 |
| Normal-VS-KIRP CIMP |
7.350200E-02 |
| Normal-VS-Unclassified PRCC |
1.537970E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.776200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.355800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.278900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.062560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.820800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.744250E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.837400E-01 |
| Normal-vs-N1 |
7.732000E-02 |
| Normal-vs-N2 |
1.910390E-01 |
| N0-vs-N1 |
5.805500E-02 |
| N0-vs-N2 |
7.617900E-02 |
| N1-vs-N2 |
7.908600E-01 |
|
|
